Aug 07 2020
A global study conducted by researchers at the Niigata University Graduate School of Medical and Dental Sciences including Associate Professor Tomoki Maekawa (also a research professor at the Institute for Research Promotion) and Professor Takeyasu Maeda of the Center for Advanced Oral Science, Professor Yutaka Terao of the Division of Microbiology and Infectious Diseases, and Professor Koichi Tabeta of the Division of Periodontology, in collaboration with the Kyoto Pharmaceutical University, the University of Pennsylvania in the US, and the Technical University of Dresden in Germany, revealed that the macrolide antibiotic erythromycin exhibited anti-inflammatory activity against pneumonia and periodontitis by inducing DEL-1.
Title: Erythromycin inhibits neutrophilic inflammation and mucosal disease by upregulating DEL-1
Journal: JCI Insight
Authors: Tomoki Maekawa, Hikaru Tamura, Hisanori Domon, Takumi Hiyoshi, Toshihito Isono, Daisuke Yonezawa, Naoki Hayashi, Naoki Takahashi, Koichi Tabeta, Takeyasu Maeda, Masataka Oda, Athanasios Ziogas, Vasileia I. Alexaki, Triantafyllos Chavakis, Yutaka Terao and George Hajishengallis
DOI: 10.1172/jci.insight.136706
Polygenic effects on the risk of Alzheimer's disease in the Japanese population
Trends in the incidence of renal replacement therapy due to rapidly progressive glomerulonephritis in Japan, 2006–2021
Uncovering The Cyclization Mechanism of Cyclic β-1,2-Glucan Synthase